Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification

PURPOSE: To estimate long-term outcomes after treatment modification in patients with chronic hepatitis B (CHB) treated with entecavir (ETV) and telbivudine (LdT). MATERIALS AND METHODS: The study enrolled 131 nucleos(t)ide analogue (NA)-naïve CHB patients treated with ETV or LdT. During the 3-year...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Yonsei Med J
Glavni autori: Choi, Jong Won, Kim, Se Hyun, Seo, Jeong Hun, Cho, Yong Suk, Won, Sun Young, Park, Byung Kyu, Jeon, Han Ho, Lee, Yong Kang, Lee, Chun Kyon
Format: Artigo
Jezik:Inglês
Izdano: Yonsei University College of Medicine 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5889990/
https://ncbi.nlm.nih.gov/pubmed/29611400
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2018.59.3.383
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items